The rapid brain growth seen in children with autism occurs early in life, before children reach 2 years of age, according to a study published in the May issue of Archives of General Psychiatry.
Spectrum: Autism Research News
Tag: brain size
Children with autism have less brain matter than normal in a region that synthesizes the social hormones oxytocin and vasopressin, according to a study published 29 April in Biological Psychiatry.
Long bundles of neurons that connect key regions in the brain develop abnormally in the first year of life in children with autism, according to new findings presented Friday at the International Meeting for Autism Research in San Diego.
Smaller-than-normal volume in several brain regions, including a region involved in relaying motor signals, could be a marker for repetitive behavior in 3-year-old children, according to a study published 7 April in Autism Research.
Men with fragile X syndrome have larger brains overall than controls do, but less matter in regions involved in language and social interaction.
The brains of people with autism show three distinct periods of abnormal development — overgrowth in infancy, prematurely arrested growth in childhood, and shrinking between adolescence and middle age — according to a study in Brain Research.
At birth, children with autism have lower blood levels of a class of antibody produced in response to infection compared with healthy controls, according to a report published in December in Autism Research.
The brains of children with autism show differences in gene expression compared with those of healthy controls, especially in genes that control cell growth. Adults with autism also have aberrant gene expression, but in different pathways, researchers reported Sunday at the Society for Neuroscience annual meeting in San Diego.
Chemicals produced by their mother’s immune system in utero alter the size of several key brain regions in people with schizophrenia, enlarging chambers that store cerebrospinal fluids, and shrinking parts of the cortex involved in processing emotion and memory.
A drug that interferes with a biochemical pathway important in cancer can reverse some brain defects in mouse models of fragile X syndrome, according to a study published 11 August in the Journal of Neuroscience.